Tahata Yuki 田畑優貴

Researcher Number	00838047
Other IDs
Affiliation (Current)	2026: 大阪大学, 大学院医学系研究科, 助教
Affiliation (based on the past Project Information) *help	2022 – 2025: 大阪大学, 大学院医学系研究科, 助教 2021: 大阪大学, 医学系研究科, 特任助教 2020: 大阪大学, 医学系研究科, 寄附講座助教
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related Except Principal Investigator Basic Section 53010:Gastroenterology-related
Keywords	Principal Investigator 脂肪性肝疾患 / 肝線維化 / 肝癌 / C型慢性肝炎 / SVR / DAA Except Principal Investigator 肝細胞死 / 細胞老化 / 慢性肝炎

脂肪性肝疾患における肝関連および他臓器イベントを予測する新規バイオマーカー探索Principal Investigator
- Principal Investigator
  
  田畑優貴
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  The University of Osaka
肝癌発生微小環境としての肝細胞死を起点とした非実質細胞の細胞老化の意義の解明
- Principal Investigator
  
  疋田隼人
- Project Period (FY)
  2024 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Osaka University
Search for novel biomarkers involved in hepatocarcinogenesis and liver fibrosis in patients with chronic hepatitis CPrincipal Investigator
- Principal Investigator
  
  Tahata Yuki
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Osaka University

All 2024 2023 2022 2021 2020

All Journal Article Presentation

[Journal Article] High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis?B patients treated with nucleos(t)ide analogs2024
- Author(s)
  Sometani E, Hikita H, Murai K, Toyoda H, Tanaka S, Oze T, Sung J, Shimoda A, Fukuoka M, Shigeno S, Fukutomi K, Shirai K, Tahata Y, Saito Y, Nishio A, Furuta K, Kodama T, Sakamori R, Tatsumi T, Mita E, Umezawa A, Tanaka Y, Takehara T.
- Journal Title
  
  Hepatology Research
  
  Volume: 55 Issue: 1 Pages: 22-33
- DOI
  10.1111/hepr.14111
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K27585
[Journal Article] Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with <scp>MASLD</scp> regardless of liver fibrosis2024
- Author(s)
  Kumazaki S, Hikita H, Tahata Y, Sung JH, Fukumoto K, Myojin Y, Sakane S, Murai K, Sasaki Y, Shirai K, Saito Y, Kodama T, Kakita N, Takahashi H, Toyoda H, Suda G, Morii E, Kojima T, Ebihara T, Shimizu K, Sasaki Y, Tatsumi T, Takehara T
- Journal Title
  
  Alimentary Pharmacology & Therapeutics
  
  Volume: 60 Issue: 3 Pages: 327-339
- DOI
  10.1111/apt.18063
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K27585
[Journal Article] Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients2022
- Author(s)
  Shirai Kumiko、Hikita Hayato、Sakane Sadatsugu、Narumi Ryohei、Adachi Jun、Doi Akira、Tanaka Satoshi、Tahata Yuki、Yamada Ryoko、Kodama Takahiro、Sakamori Ryotaro、Tatsumi Tomohide、Mita Eiji、Tomonaga Takeshi、Takehara Tetsuo
- Journal Title
  
  PLOS ONE
  
  Volume: 17 Issue: 7 Pages: e0271020-e0271020
- DOI
  10.1371/journal.pone.0271020
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16956
[Journal Article] Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis2022
- Author(s)
  Tahata Yuki、Sakamori Ryotaro、Yamada Ryoko、et al.
- Journal Title
  
  Hepatology Research
  
  Volume: 52 Issue: 10 Pages: 824-832
- DOI
  10.1111/hepr.13806
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16956
[Journal Article] Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct‐acting anti‐virals2021
- Author(s)
  Tahata Yuki、Sakamori Ryotaro、Yamada Ryoko、Kodama Takahiro、Hikita Hayato、Tatsumi Tomohide、Takehara Tetsuo、the Osaka Liver Forum
- Journal Title
  
  Alimentary Pharmacology & Therapeutics
  
  Volume: 54 Issue: 10 Pages: 1340-1349
- DOI
  10.1111/apt.16632
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07894, KAKENHI-PROJECT-20K16956
[Journal Article] Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment2020
- Author(s)
  Tahata Yuki、Sakamori Ryotaro、Urabe Ayako、Yamada Ryoko、Ohkawa Kazuyoshi、Hiramatsu Naoki、Hagiwara Hideki、Oshita Masahide、Imai Yasuharu、Kodama Takahiro、Hikita Hayato、Tatsumi Tomohide、Takehara Tetsuo
- Journal Title
  
  Hepatology Research
  
  Volume: 50 Issue: 10 Pages: 1118-1127
- DOI
  10.1111/hepr.13547
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16956
[Presentation] Serum GDF15 level, in combination with the FIB-4 index, is useful for refining the identification of high-risk patients for clinical event occurrence in MASLD patients2024
- Author(s)
  Hayato Hikita, Yuki Tahata, et al.
- Organizer
  The International Liver Congress 2024, EASL
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27585
[Presentation] Serum GDF15 is a novel predictive biomarker for liver cancer occurrence in patients with MASLD2024
- Author(s)
  Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Takahiro Kodama, Naruyasu Kakita, Hirokazu Takahashi, Hidenori Toyoda, Goki Suda, Tomohide Tatsumi, Tetsuo Takehara
- Organizer
  The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver（APASL2024）
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27585
[Presentation] 非アルコール性脂肪性肝疾患における肝発癌高リスク群の絞り込みの検討2023
- Author(s)
  疋田隼人　熊崎秀祐　田畑優貴小玉尚宏　垣田成庸高橋和宏豊田秀徳　須田剛生　竹原徹郎
- Organizer
  第9回肝と糖尿病代謝研究会
- Data Source
  KAKENHI-PROJECT-23K27585
[Presentation] GDF15 is a novel predictive marker for development of NAFLD-associated liver cancer2023
- Author(s)
  Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Kenji Fukumoto, Sadatsugu Sakane, Kazuhiro Murai, Takahiro Kodama, Naruyasu Kakita, Hirokazu Takahashi, Hidenori Toyoda, Goki Suda, Tomohide Tatsumi, Tetsuo Takehara
- Organizer
  AASLD The Liver Meeting 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27585
[Presentation] Risk factor of hepatocellular carcinoma occurrence after sustained virologic responses in hepatitis C virus patients without advanced liver fibrosis2022
- Author(s)
  Yuki Tahata, Ryotaro Sakamori, Ryoko Yamada, et al.
- Organizer
  AASLD The Liver Meeting 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16956
[Presentation] DAA治療時代におけるSVR後肝発癌予測モデルの検討2021
- Author(s)
  田畑優貴、阪森亮太郎、竹原徹郎
- Organizer
  第25回日本肝臓学会大会
- Data Source
  KAKENHI-PROJECT-20K16956

1. 疋田隼人 (20623044)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
2. 巽智秀

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 小玉尚宏

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tahata Yuki 田畑 優貴

Research Projects

Research Products

Co-Researchers

脂肪性肝疾患における肝関連および他臓器イベントを予測する新規バイオマーカー探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肝癌発生微小環境としての肝細胞死を起点とした非実質細胞の細胞老化の意義の解明

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Search for novel biomarkers involved in hepatocarcinogenesis and liver fibrosis in patients with chronic hepatitis CPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis?B patients treated with nucleos(t)ide analogs2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with <scp>MASLD</scp> regardless of liver fibrosis2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct‐acting anti‐virals2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] Serum GDF15 level, in combination with the FIB-4 index, is useful for refining the identification of high-risk patients for clinical event occurrence in MASLD patients2024

Author(s)

Organizer

Data Source

[Presentation] Serum GDF15 is a novel predictive biomarker for liver cancer occurrence in patients with MASLD2024

Author(s)

Organizer

Data Source

[Presentation] 非アルコール性脂肪性肝疾患における肝発癌高リスク群の絞り込みの検討2023

Author(s)

Organizer

Data Source

[Presentation] GDF15 is a novel predictive marker for development of NAFLD-associated liver cancer2023

Author(s)

Organizer

Data Source

[Presentation] Risk factor of hepatocellular carcinoma occurrence after sustained virologic responses in hepatitis C virus patients without advanced liver fibrosis2022

Author(s)

Organizer

Data Source

[Presentation] DAA治療時代におけるSVR後肝発癌予測モデルの検討2021

Author(s)

Organizer

Data Source

Tahata Yuki 田畑優貴